Donald P McDonnell

33PUBLICATIONS
204CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCheminformatics and quantitative structure-activity relationshipsEnergy generation, conversion and storage (excl. chemical and electrical)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|May 13, 2026
Single-Cell Transcriptomics Reveals Immune Landscape Dynamics in Metastatic Hormone Receptor-Positive Breast Cancer Treated with Abemaciclib and Endocrine Therapy.

|Mar 18, 2026
Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6.

Anne Fassl, Miriam Palacios Espinoza, Deborah Butter

|Dec 12, 2025
The Selective Estrogen Receptor Degrader ZN-c5 Has Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models.

Jianhui Ma, Sayee Hegde, Masha Sergeeva

|Sep 11, 2025
Targeting the ERα DBD-LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation.

Han Wang, Yuxuan Luo, Sandeep Artham

|Aug 11, 2025
Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.

Surendra Nayak, John D Norris, Massimo Ammirante

|May 09, 2025
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens.

Jovita Byemerwa, Ching-Yi Chang, Donald P McDonnell

Pageof 6

Frequent Collaborators

9 joint publications

Suzanne E Wardell

5 joint publications

Ching-Yi Chang

5 joint publications

Sandeep Artham

4 joint publications

Binita Chakraborty